* Core strengths in ADME, with expertise in drug metabolism of small molecules, PROTACs & peptides utilizing traditional methods and software tools for metabolite identification with high resolution mass spectrometers.* Proactively provides perspective and structural/bioisosteric input to discovery working groups to influence compound design/selection with focus to anticipate or address potential biotransformation issues including high metabolic CL, bioactivation, structural alerts and active metabolites during program progression. * Expertise in pharmacokinetic analysis of small molecules. Proficient in integrating biotransformation, pharmacokinetic and transporters mechanism to understand complex PK/ADME in preclinical species and translating into humans.* Actively working in collaborative, cross-functional teams for developing a drug candidates.* Well-versatile in Mass-MetaSite & WebMetabase for automated metabolite ID, data storage, report generation* Key contributor for a highly integrated team (internal and external) for the design and characterization of liver microphysiological systems (MPS).